Review
doi: 10.1038/ncpendmet0195.
Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders
Affiliations
- PMID: 16932322
- DOI: 10.1038/ncpendmet0195
Item in Clipboard
Review
Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders
Nat Clin Pract Endocrinol Metab.
2006 Jul.
Abstract
Advances in the diagnosis and treatment of growth hormone insensitivity disorders have occurred in the past 15 years. We discuss the current status of endocrine and molecular evaluation, focusing on the pediatric age range. All the identified mutations of the growth hormone receptor are included. Treatment with recombinant human insulin-like growth factor (rhIGF) 1 in classical cases is summarized and new targets for treatment are discussed, together with therapy using the complex formed between rhIGF1 and rhIGF-binding protein 3.
Similar articles
-
Diagnostic and therapeutic advances in growth hormone insensitivity.Endocrinol Metab Clin North Am. 2005 Sep;34(3):581-95, viii. doi: 10.1016/j.ecl.2005.04.009. Endocrinol Metab Clin North Am. 2005. PMID: 16085161 Review.
-
Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.Growth Horm IGF Res. 2007 Aug;17(4):307-14. doi: 10.1016/j.ghir.2007.03.001. Epub 2007 Apr 25. Growth Horm IGF Res. 2007. PMID: 17462934
-
A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.Growth Horm IGF Res. 2016 Jun;28:46-50. doi: 10.1016/j.ghir.2015.08.001. Epub 2015 Aug 9. Growth Horm IGF Res. 2016. PMID: 26276451
-
Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.Zhongguo Dang Dai Er Ke Za Zhi. 2007 Aug;9(4):335-8. Zhongguo Dang Dai Er Ke Za Zhi. 2007. PMID: 17706034
-
Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).Pediatr Endocrinol Rev. 2008 Mar;5(3):766-71. Pediatr Endocrinol Rev. 2008. PMID: 18367997 Review.
Cited by
-
Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein.Clin Endocrinol (Oxf). 2020 Apr;92(4):331-337. doi: 10.1111/cen.14148. Epub 2020 Jan 22. Clin Endocrinol (Oxf). 2020. PMID: 31883394 Free PMC article.
-
Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.J Clin Oncol. 2010 Nov 20;28(33):4985-95. doi: 10.1200/JCO.2009.27.5040. Epub 2010 Oct 25. J Clin Oncol. 2010. PMID: 20975071 Free PMC article. Review.
-
Regulation of muscle mass by growth hormone and IGF-I.Br J Pharmacol. 2008 Jun;154(3):557-68. doi: 10.1038/bjp.2008.153. Br J Pharmacol. 2008. PMID: 18500379 Free PMC article. Review.
-
Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature.J Cell Mol Med. 2017 Nov;21(11):2985-2999. doi: 10.1111/jcmm.13210. Epub 2017 May 29. J Cell Mol Med. 2017. PMID: 28557176 Free PMC article.
-
Genetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth.Front Endocrinol (Lausanne). 2011 Dec 12;2:95. doi: 10.3389/fendo.2011.00095. eCollection 2011. Front Endocrinol (Lausanne). 2011. PMID: 22654835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous